Exam 2: Anxiolytics Flashcards
BZDs Place in anxiety therapy: Acute (4)
- rapid relief needed
- imitation of antidepressants
- Generally NOT 1st line
- MAX 6 weeks then taper dose
- taper depends on drug, dose, duration
BZDs place in anxiety therapy: long term use
reserved for severe, refractory anxiety cases
-refer to specialist!
Antidepressants for anxiety: Follow-up (2)
- every 1-2 weeks
2. monthly thereafter
Antidepressants for anxiety: efficacy (2)
- 4-6 week trial
2. remission/partial response/no response
Antidepressants for anxiety: maintenance (2)
- typically 12+ months at full dose
2. taper medication if no residual symptoms
Antidepressants for anxiety: initial dosing (2)
- start small
- Rule of thumb: use hand initial antidepressant dose - patients often need higher doses for efficacy
Buspirone
MOA place in tx for anxiety dosing Avoidance? Adverse Effects
- MOA: partial agonist 5-HT1a receptor
- 2nd line tx for GAD
- FDA approved
- monotherapy OR augmentation - 7.5 mg BID, up to 60mg today per day
- delayed onset of effect: ~2 weeks
- AVOID IN SEVERE HEPATIC/RENAL IMPAIRMENT - AE: dizziness, nausea, HA, akathisia (restlessness)
Hydroxyzine Pamoate/hcl
MOA
block histaminic H-1 and serotonins 5-HT2 receptors, CNS depression
Hydroxyzine Pamoate/ HCL
place in tx for anxiety
2nd line agent for GAD
- rapid effects: 15-30 minuts onset
- dose: 25-100mg up to 4x daily
Hydroxyzine Pamoate/HC adverse effectsl (3)
- CNS depression
- anticholingeric effects
- QTc prolongation
Hydroxyzine Pamoate/HCL usefulness (3)
- may be useful in abuse Hx
- insomnia
- pediatric anxiety
Propranolol MOA
blocks cardiac beta receptor activation
- decreases HR and force contraction
- decreased BP
- Dose ~ 40 mg IR about 1 hour prior to event
Propranolol benefits
event-related anxiety
*off-label use
Propranolol Adverse Effects (3)
- low BP
- fatigue
- cold extremeties
Pregabalin (2)
- considered 1st line in some guidelines
- some acute efficacy in GAD - not FDA approved